Next Article in Journal
Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions
Previous Article in Journal
Assessing the Tumor Suppressive Impact and Regulatory Mechanisms of SPDEF Expression in Breast Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 17
Issue 21
10.3390/cancers17213557
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Cancers 2025, 17(9), 1470.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Alzahrani et al. Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy. Cancers 2025, 17, 1470

by
Shiekhah Mohammad Alzahrani
1,2,
Huda Abdulaziz Al Doghaither
1,*,
Hind Ali Alkhatabi
3,
Mohammad Abdullah Basabrain
2,4 and
Peter Natesan Pushparaj
2,4
1
Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589 P.O. Box 80200, Saudi Arabia
2
Institute of Genomic Medicine Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah P.O. Box 21589, Saudi Arabia
3
Department of Biological Science, College of Science, University of Jeddah, Jeddah P.O. Box 21589, Saudi Arabia
4
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah P.O. Box 21589, Saudi Arabia
*
Author to whom correspondence should be addressed.
Cancers 2025, 17(21), 3557; https://doi.org/10.3390/cancers17213557
Submission received: 17 October 2025 / Accepted: 20 October 2025 / Published: 3 November 2025
(This article belongs to the Section Cancer Therapy)
Browse Figures
Versions Notes

1. Affiliations

In the original publication [1], there was an error with the affiliation (1). The P.O. box number has been added.

2. Figure/Table Legend

In the original publication [1], there was a mistake with Figures 3 and 6. For Figure 3, the yellow highlight boxes have been removed and for Figure 6, GCLC has been replaced with GCLM and SLC3A2 with SLC7A11. The figures appear below.
Cancers 17 03557 g003aCancers 17 03557 g003bCancers 17 03557 g003cCancers 17 03557 g003dCancers 17 03557 g003e
Figure 3. Overall view of the transcriptomic and metabolomic profiles of HT-29 cells after treatment with PRO and/or CAP compared with untreated cells. (A) Heatmap showing the expression pattern of genes in HT-29-treated groups versus the control group. (B) Volcano plot showing the positions of differentially upregulated and downregulated genes in the PRO, CAP, and PRO + CAP groups versus the control group. (C) Total ion chromatograms of the extracted metabolites from treated and untreated HT-29 cells, which were run in LTQ-XL linear ion trap LC-MS. (D) Principal component analysis (PCA) of comprehensive metabolites from treated and untreated HT-29 cells. (E) Correlation heatmaps of treated and untreated HT-29 cells. (F) Heatmaps of differentially expressed metabolites in treated and untreated HT-29 cells. (G) The top twenty-five pathways enriched in the metabolome analysis of treated and untreated HT-29 cell lines.
Figure 3. Overall view of the transcriptomic and metabolomic profiles of HT-29 cells after treatment with PRO and/or CAP compared with untreated cells. (A) Heatmap showing the expression pattern of genes in HT-29-treated groups versus the control group. (B) Volcano plot showing the positions of differentially upregulated and downregulated genes in the PRO, CAP, and PRO + CAP groups versus the control group. (C) Total ion chromatograms of the extracted metabolites from treated and untreated HT-29 cells, which were run in LTQ-XL linear ion trap LC-MS. (D) Principal component analysis (PCA) of comprehensive metabolites from treated and untreated HT-29 cells. (E) Correlation heatmaps of treated and untreated HT-29 cells. (F) Heatmaps of differentially expressed metabolites in treated and untreated HT-29 cells. (G) The top twenty-five pathways enriched in the metabolome analysis of treated and untreated HT-29 cell lines.
Cancers 17 03557 g003aCancers 17 03557 g003bCancers 17 03557 g003cCancers 17 03557 g003dCancers 17 03557 g003e
Cancers 17 03557 g006
Figure 6. Proposed mechanism of combined therapy in HT-29 cell line based on RNA-seq results. The figure was created with BioRender (www.biorender.com).
Figure 6. Proposed mechanism of combined therapy in HT-29 cell line based on RNA-seq results. The figure was created with BioRender (www.biorender.com).
Cancers 17 03557 g006

3. Supplementary Files

In the original supplementary files, there was a typo for the reference list used in Table S4. The name of the reference list has been changed from “References of Table S6” to “References of Table S4”.
The scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Alzahrani, S.M.; Al Doghaither, H.A.; Alkhatabi, H.A.; Basabrain, M.A.; Pushparaj, P.N. Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy. Cancers 2025, 17, 1470. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alzahrani, S.M.; Al Doghaither, H.A.; Alkhatabi, H.A.; Basabrain, M.A.; Pushparaj, P.N. Correction: Alzahrani et al. Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy. Cancers 2025, 17, 1470. Cancers 2025, 17, 3557. https://doi.org/10.3390/cancers17213557

AMA Style

Alzahrani SM, Al Doghaither HA, Alkhatabi HA, Basabrain MA, Pushparaj PN. Correction: Alzahrani et al. Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy. Cancers 2025, 17, 1470. Cancers. 2025; 17(21):3557. https://doi.org/10.3390/cancers17213557

Chicago/Turabian Style

Alzahrani, Shiekhah Mohammad, Huda Abdulaziz Al Doghaither, Hind Ali Alkhatabi, Mohammad Abdullah Basabrain, and Peter Natesan Pushparaj. 2025. "Correction: Alzahrani et al. Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy. Cancers 2025, 17, 1470" Cancers 17, no. 21: 3557. https://doi.org/10.3390/cancers17213557

APA Style

Alzahrani, S. M., Al Doghaither, H. A., Alkhatabi, H. A., Basabrain, M. A., & Pushparaj, P. N. (2025). Correction: Alzahrani et al. Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy. Cancers 2025, 17, 1470. Cancers, 17(21), 3557. https://doi.org/10.3390/cancers17213557

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop